France Immunoassay Market Size, Share, and COVID-19 Impact Analysis, By Technology (Radioimmunoassay, Enzyme Immunoassays), By Application (Therapeutic Drug Monitoring, Oncology and Infectious Disease), and France Immunoassay Market Insights, Industry Trend, Forecasts to 2035

France Immunoassay Market Insights Forecasts to 2035 

• The France Immunoassay Market Size was Estimated at USD 668.3 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.19% from 2025 to 2035
• The France Immunoassay Market Size is Expected to Reach USD 1165.5 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The France Immunoassay Market Size is anticipated to Reach USD 1165.5 Million by 2035, Growing at a CAGR of 5.19% from 2025 to 2035. This is due to precision medicine is becoming more and more popular.  Through the identification of biomarkers that predict responses to particular therapies, immunoassay plays a critical role in customizing treatments for each patient. 

Market Overview 

The France Immunoassay Market Size defines the supply and demand for immunoassay, as immunoassay is a biochemical test using antibodies to detect and measure substances of interest in a sample. The ability to find out whether a substance is found in solution in more or less concentration in an immunoassay is invaluable in different applications, since these solutions could be complex. Immunoassay systems provide enormous contributions to the individualization of treatments for patients by discovering the biomarkers correlated to the response of patients to specific therapies. Increasing burden and incidence of cancer, cardiovascular diseases, and autoimmunity have fostered the use of targeted therapies whose immunoassay-based systems recognize the therapies that would be most efficacious for patients under the care pathway. Reducing side effects, therefore increasing the efficacy of treatments and subsequently resulting in better patient outcomes, is the movement of shifting away from one-size-fits-all treatment to personalized medicine, and it therefore fuels a great volume of growth in the immunoassay market. 

Report Coverage

This research report categorizes the market size for the France immunoassay market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France immunoassay market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France immunoassay market. 

Driving Factors

The major factor driving growth in the market is the rapid advancement of diagnostics technologies overall. Improvements in lateral flow assays, ELISA (enzyme-linked immunosorbent assay), radioimmunoassay, and other related technologies allow for the more accurate and efficient identification of biomarkers. These developments enable the more rapid and accurate detection of infectious agents, cancer biomarkers, genetic markers, drugs, toxins, and hormones critical to personalized medicine treatment decisions. 

Restraining Factors

The France immunoassay market has several challenges, including the high costs of advanced technologies, a shortage of skilled people, infrastructure constraints, and regulatory issues. Collectively, these challenges can hinder the adoption of immunoassay technology, especially among smaller labs and those with limited resources.

Market Segmentation

The France immunoassay market share is classified into technology and application.

• The enzyme immunoassays segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France immunoassay market is segmented by technology into radioimmunoassay, enzyme immunoassays. Among these, the enzyme immunoassays segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to concentrating on infectious disease detection, cardiovascular disease testing, cancer diagnostics, and personalized medicine.  This method, which offers extremely sensitive and specific detection of a variety of biomarkers, is widely used in the market.  Research, environmental testing, and clinical diagnostics have all benefited greatly from this technology.

• The infectious disease segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The France immunoassay market is segmented by application into therapeutic drug monitoring, oncology, and infectious disease. Among these, the infectious disease segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This significant portion is explained by the rise in infectious diseases and the increased focus on early detection and individualized treatment strategies. In infectious diseases, immunoassay seeks to efficiently manage risk factors and maximize drug selection.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France immunoassay market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. 

List of Key Companies

• Abbott
• Quidel Corporation
• Ortho Clinical Diagnostics
• Danaher Corporation (Beckman Coulter)
• bioMérieux SA
• Sysmex Corporation
• Bio-Rad Laboratories, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the France Immunoassay Market based on the below-mentioned segments:

France Immunoassay Market, By Technology                                               

• Radioimmunoassay
• Enzyme Immunoassays

France Immunoassay Market, By Application                                                          

• Therapeutic Drug Monitoring
• Oncology
• Infectious Disease